View Future GrowthAlbert David 과거 순이익 실적과거 기준 점검 0/6Albert David 의 수입은 연평균 -11.1%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 연평균 14.2%의 비율로 증가했습니다. 매출은 연평균 3.7%의 비율로 증가해 왔습니다.핵심 정보-11.12%순이익 성장률-11.12%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률17.49%매출 성장률3.73%자기자본이익률-0.38%순이익률-0.45%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • May 14Full year 2026 earnings released: ₹2.62 loss per share (vs ₹30.14 profit in FY 2025)Full year 2026 results: ₹2.62 loss per share (down from ₹30.14 profit in FY 2025). Revenue: ₹3.41b (down 1.4% from FY 2025). Net loss: ₹14.9m (down 109% from profit in FY 2025). Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.공시 • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.공시 • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.공시 • Nov 03Albert David Limited to Report Q2, 2026 Results on Nov 12, 2025Albert David Limited announced that they will report Q2, 2026 results on Nov 12, 2025모든 업데이트 보기Recent updatesDeclared Dividend • May 14Dividend of ₹5.00 announcedDividend of ₹5.00 is the same as last year. Ex-date: 30th July 2026 Payment date: 5th September 2026 Dividend yield will be 0.7%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.Reported Earnings • May 14Full year 2026 earnings released: ₹2.62 loss per share (vs ₹30.14 profit in FY 2025)Full year 2026 results: ₹2.62 loss per share (down from ₹30.14 profit in FY 2025). Revenue: ₹3.41b (down 1.4% from FY 2025). Net loss: ₹14.9m (down 109% from profit in FY 2025). Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.공시 • May 13Albert David Limited, Annual General Meeting, Aug 06, 2026Albert David Limited, Annual General Meeting, Aug 06, 2026.공시 • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.분석 기사 • Feb 14Is Albert David (NSE:ALBERTDAVD) Weighed On By Its Debt Load?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...공시 • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.공시 • Nov 03Albert David Limited to Report Q2, 2026 Results on Nov 12, 2025Albert David Limited announced that they will report Q2, 2026 results on Nov 12, 2025공시 • Jul 25Albert David Limited to Report Q1, 2026 Results on Aug 02, 2025Albert David Limited announced that they will report Q1, 2026 results at 12:15 PM, Indian Standard Time on Aug 02, 2025Upcoming Dividend • Jul 18Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 25 July 2025. Payment date: 07 August 2025. Payout ratio is a comfortable 17% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.8%).Reported Earnings • Jul 10Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.46b (down 4.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 5.0% (down from 21% in FY 2024). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 16% per year.분석 기사 • May 24Albert David's (NSE:ALBERTDAVD) Weak Earnings May Only Reveal A Part Of The Whole PictureThe market wasn't impressed with the soft earnings from Albert David Limited ( NSE:ALBERTDAVD ) recently. Our analysis...Declared Dividend • May 15Dividend reduced to ₹5.00Dividend of ₹5.00 is 57% lower than last year. Ex-date: 25th July 2025 Payment date: 1st September 2025 Dividend yield will be 0.6%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to decline by 90% to shift the payout ratio to a potentially unsustainable range, which is more than the 2.1% EPS decline seen over the last 5 years.공시 • May 14+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 02, 2025Albert David Limited, Annual General Meeting, Aug 02, 2025.Reported Earnings • May 14Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.75b (up 3.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 4.6% (down from 21% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 15% per year.New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (₹5.14b market cap, or US$60.5m).공시 • Mar 10Albert David Limited Announces Resignation of Shirish Gundopant Belapure as Independent DirectorAlbert David Limited announced that Mr. Shirish Gundopant Belapure has tendered his resignation as an Independent Director of the company, with effect from March 10, 2025.Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹885, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 28x in the Pharmaceuticals industry in India. Total returns to shareholders of 69% over the past three years.분석 기사 • Feb 14Albert David Limited (NSE:ALBERTDAVD) Not Doing Enough For Some Investors As Its Shares Slump 27%The Albert David Limited ( NSE:ALBERTDAVD ) share price has fared very poorly over the last month, falling by a...Reported Earnings • Feb 13Third quarter 2025 earnings released: ₹16.45 loss per share (vs ₹32.80 profit in 3Q 2024)Third quarter 2025 results: ₹16.45 loss per share (down from ₹32.80 profit in 3Q 2024). Revenue: ₹740.8m (down 16% from 3Q 2024). Net loss: ₹93.9m (down 150% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.공시 • Feb 01Albert David Limited to Report Q3, 2025 Results on Feb 12, 2025Albert David Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 12, 2025분석 기사 • Nov 22Albert David's (NSE:ALBERTDAVD) Attractive Earnings Are Not All Good News For ShareholdersThe latest earnings release from Albert David Limited ( NSE:ALBERTDAVD ) disappointed investors. We did some digging...Reported Earnings • Nov 17Second quarter 2025 earnings released: EPS: ₹31.67 (vs ₹35.57 in 2Q 2024)Second quarter 2025 results: EPS: ₹31.67 (down from ₹35.57 in 2Q 2024). Revenue: ₹1.19b (up 28% from 2Q 2024). Net income: ₹180.7m (down 11% from 2Q 2024). Profit margin: 15% (down from 22% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 30% per year.공시 • Nov 09Albert David Limited to Report Q2, 2025 Results on Nov 14, 2024Albert David Limited announced that they will report Q2, 2025 results on Nov 14, 2024분석 기사 • Aug 31A Piece Of The Puzzle Missing From Albert David Limited's (NSE:ALBERTDAVD) 26% Share Price ClimbDespite an already strong run, Albert David Limited ( NSE:ALBERTDAVD ) shares have been powering on, with a gain of 26...Buy Or Sell Opportunity • Aug 29Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 46% to ₹1,629. The fair value is estimated to be ₹1,314, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Earnings per share has grown by 31%.Valuation Update With 7 Day Price Move • Aug 23Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹1,448, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 37x in the Pharmaceuticals industry in India. Total returns to shareholders of 163% over the past three years.공시 • Aug 09Albert David Limited Approves Dividend for the Financial Year Ended on March 31, 2024Albert David Limited at the Annual General Meeting held on August 9, 2024 approved declaration of Dividend of INR 11.50 per equity share of INR 10 each for the financial year ended on March 31, 2024.분석 기사 • Jul 30Albert David (NSE:ALBERTDAVD) Is Increasing Its Dividend To ₹11.50Albert David Limited ( NSE:ALBERTDAVD ) has announced that it will be increasing its dividend from last year's...Buy Or Sell Opportunity • Jul 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 11% to ₹1,326. The fair value is estimated to be ₹1,103, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.Upcoming Dividend • Jul 26Upcoming dividend of ₹11.50 per shareEligible shareholders must have bought the stock before 02 August 2024. Payment date: 08 September 2024. Payout ratio is a comfortable 8.7% and this is well supported by cash flows. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).분석 기사 • Jul 16Albert David (NSE:ALBERTDAVD) Has Announced That It Will Be Increasing Its Dividend To ₹11.50Albert David Limited ( NSE:ALBERTDAVD ) has announced that it will be increasing its dividend from last year's...Reported Earnings • Jul 15Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹3.62b (up 6.1% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 21% (up from 11% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.Buy Or Sell Opportunity • Jul 01Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to ₹1,361. The fair value is estimated to be ₹1,103, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.Buy Or Sell Opportunity • Jun 21Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to ₹1,335. The fair value is estimated to be ₹1,105, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,269, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 33x in the Pharmaceuticals industry in India. Total returns to shareholders of 156% over the past three years.분석 기사 • May 21We Think That There Are Issues Underlying Albert David's (NSE:ALBERTDAVD) EarningsUnsurprisingly, Albert David Limited's ( NSE:ALBERTDAVD ) stock price was strong on the back of its healthy earnings...Declared Dividend • May 15Dividend of ₹11.50 announcedShareholders will receive a dividend of ₹11.50. Ex-date: 2nd August 2024 Payment date: 8th September 2024 Dividend yield will be 1.0%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (14% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 34% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • May 15Albert David Limited, Annual General Meeting, Aug 09, 2024Albert David Limited, Annual General Meeting, Aug 09, 2024.Reported Earnings • May 14Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹4.20b (up 23% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 18% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.공시 • May 07Albert David Limited to Report Q4, 2024 Results on May 13, 2024Albert David Limited announced that they will report Q4, 2024 results on May 13, 2024공시 • May 06Albert David Limited Announces Resignation of Abhishek Seth as Company Secretary & Compliance Officer, Effective May 31, 2024Albert David Limited informed that Mr. Abhishek Seth (ACS - 39671), Company Secretary & Compliance Officer, has resigned from the services of the Company effective May 31, 2024, in view of career opportunity outside the organization. In view of the resignation, Mr. Seth will also cease to be a Key Managerial Person under the provisions of Section 203 and other applicable provisions, if any, of the Companies Act, 2013 and Regulation 30(5) of the SEBI Listing Regulations for determining materiality of events /information for disclosure to the Stock Exchanges.분석 기사 • Mar 20Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price SlumpAlbert David Limited ( NSE:ALBERTDAVD ) shares have retraced a considerable 25% in the last month, reversing a fair...공시 • Mar 14Albert David Limited Announces Management ChangesAlbert David Limited at its board meeting held on 14 March 2024 announced that Based on the recommendation of the Nomination and Remuneration Committee of the Company, appointed Mr. Abhishek Seth (ACS-39671) as the Company Secretary & Compliance Officer, Nodal Officer (IEPF) and Chief Investor Relations Officer of the Company effective 14th March 2024 and Noted that Mr. Rajiv Singhi (DIN:00071285) and Mr. Hemal Kampani (DIN:00057715), Independent Directors of the Company, will be completing their second & final term as Independent Directors effective end of day 31st March 2024, and, thus, placed on record their appreciation for the retiring Directors. Reason for change of Mr. Abhishek Seth: In view of resignation of earlier Company Secretary & Compliance Officer-cum-Legal Head of the Company, and, based on recommendation of the Nomination and Remuneration Committee of the Company, the Board has appointed Mr. Abhishek Seth as the Company Secretary & Compliance Officer of the Company, who shall also function as the Nodal Officer (IEPF) and Chief Investor Relations Officer. Mr. Abhishek Seth is an Associate Member of the Institute of Company Secretaries of India (Membership No. 39671) and holds a Master's in Economics from University of Calcutta. He has around 9 years of post-qualification experience in the Corporate Secretarial and Compliance domain. He has been associated with Albert David Limited for nearly 8 years across Corporate Secretarial, Compliance and Finance functions. Prior to association with Albert David Limited, he was associated with Bengal Shelter Housing Development Limited as Company Secretary.Reported Earnings • Feb 06Third quarter 2024 earnings released: EPS: ₹32.80 (vs ₹18.48 in 3Q 2023)Third quarter 2024 results: EPS: ₹32.80 (up from ₹18.48 in 3Q 2023). Revenue: ₹1.05b (up 41% from 3Q 2023). Net income: ₹187.2m (up 78% from 3Q 2023). Profit margin: 18% (up from 14% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.공시 • Jan 26Albert David Limited to Report Q3, 2024 Results on Feb 05, 2024Albert David Limited announced that they will report Q3, 2024 results on Feb 05, 2024Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,271, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 35x in the Pharmaceuticals industry in India. Total returns to shareholders of 207% over the past three years.분석 기사 • Jan 20The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do MoreAlbert David Limited ( NSE:ALBERTDAVD ) shares have continued their recent momentum with a 33% gain in the last month...공시 • Nov 23Albert David Limited Announces Resignation of A. B. Chakrabartty as Company Secretary and Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that Mr. A. B. Chakrabartty (FCS 7184) has conveyed his decision to resign from the post of Company Secretary and Compliance Officer cum Legal Head of the Company, due to career opportunity outside the organization. He will continue to discharge his duties as the Company Secretary and Compliance Officer cum Legal Head of the Company, until the close of business hours on 19 January, 2024 to facilitate smooth transition. The Company has accepted his resignation. Mr. Chakrabartty will also cease to be a Key Managerial Personnel under the provisions of Section 203 and other applicable provisions, if any of the Companies Act, 2023 and Regulation 30(5) of SEBI LODR for determining the materiality of events or transactions for making the required disclosures to the Stock Exchanges effective close of business hours on January 19, 2024.Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹35.57 (vs ₹35.29 in 2Q 2023)Second quarter 2024 results: EPS: ₹35.57 (up from ₹35.29 in 2Q 2023). Revenue: ₹1.05b (up 14% from 2Q 2023). Net income: ₹203.0m (flat on 2Q 2023). Profit margin: 19% (down from 22% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.공시 • Aug 11Albert David Limited Approves Dividend for the Financial Year Ended March 31, 2023Albert David Limited at its AGM held on August 10, 2023 approved dividend of INR 9.00 per equity share of INR 10.00 each for the financial year ended on 31st March, 2023.Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹41.16 (vs ₹3.08 in 1Q 2023)First quarter 2024 results: EPS: ₹41.16 (up from ₹3.08 in 1Q 2023). Revenue: ₹1.10b (up 18% from 1Q 2023). Net income: ₹234.9m (up ₹217.4m from 1Q 2023). Profit margin: 21% (up from 1.9% in 1Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.공시 • Aug 03Albert David Limited to Report Q1, 2024 Results on Aug 10, 2023Albert David Limited announced that they will report Q1, 2024 results on Aug 10, 2023Upcoming Dividend • Jul 27Upcoming dividend of ₹9.00 per share at 1.3% yieldEligible shareholders must have bought the stock before 03 August 2023. Payment date: 09 September 2023. Payout ratio is a comfortable 14% and the cash payout ratio is 98%. Trailing yield: 1.3%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%).분석 기사 • Jul 04Albert David (NSE:ALBERTDAVD) Will Pay A Dividend Of ₹9.00Albert David Limited's ( NSE:ALBERTDAVD ) investors are due to receive a payment of ₹9.00 per share on 9th of...분석 기사 • May 22Albert David (NSE:ALBERTDAVD) Is Paying Out A Dividend Of ₹9.00The board of Albert David Limited ( NSE:ALBERTDAVD ) has announced that it will pay a dividend on the 9th of September...Reported Earnings • May 21Full year 2023 earnings released: EPS: ₹63.39 (vs ₹61.78 in FY 2022)Full year 2023 results: EPS: ₹63.39 (up from ₹61.78 in FY 2022). Revenue: ₹3.57b (up 14% from FY 2022). Net income: ₹361.7m (up 2.6% from FY 2022). Profit margin: 10% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.공시 • May 20+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 10, 2023Albert David Limited, Annual General Meeting, Aug 10, 2023. Agenda: To consider dividend for the financial year ended March 31, 2023; and to consider directorate appointments.공시 • May 13Albert David Limited to Report Q4, 2023 Results on May 19, 2023Albert David Limited announced that they will report Q4, 2023 results on May 19, 2023Reported Earnings • Feb 15Third quarter 2023 earnings released: EPS: ₹18.48 (vs ₹13.96 in 3Q 2022)Third quarter 2023 results: EPS: ₹18.48 (up from ₹13.96 in 3Q 2022). Revenue: ₹745.7m (up 4.0% from 3Q 2022). Net income: ₹105.5m (up 32% from 3Q 2022). Profit margin: 14% (up from 11% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.공시 • Feb 07Albert David Limited to Report Q3, 2023 Results on Feb 13, 2023Albert David Limited announced that they will report Q3, 2023 results on Feb 13, 2023공시 • Feb 06+ 1 more updateAlbert David Limited Appoints Mr. A B Chakrabartty as the Company Secretary & Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that at its board meeting held on February 04, 2023, the board approved the appointment of Mr. A B Chakrabartty as the Company Secretary & Compliance officer cum Legal Head of the company with effect from February 04, 2023.Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹35.29 (vs ₹22.20 in 2Q 2022)Second quarter 2023 results: EPS: ₹35.29 (up from ₹22.20 in 2Q 2022). Revenue: ₹1.06b (up 23% from 2Q 2022). Net income: ₹201.4m (up 59% from 2Q 2022). Profit margin: 19% (up from 15% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Jul 25Upcoming dividend of ₹9.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 08 September 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (1.0%).Reported Earnings • Jul 17Full year 2022 earnings releasedFull year 2022 results: Revenue: ₹3.14b (up 27% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021).Recent Insider Transactions • Jun 19Executive Chairman recently bought ₹1.1m worth of stockOn the 13th of June, Arun Kothari bought around 2k shares on-market at roughly ₹526 per share. In the last 3 months, they made an even bigger purchase worth ₹1.4m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹7.3m worth in shares.Reported Earnings • May 13Full year 2022 earnings released: EPS: ₹61.78 (vs ₹38.80 in FY 2021)Full year 2022 results: EPS: ₹61.78 (up from ₹38.80 in FY 2021). Revenue: ₹3.29b (up 33% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Apr 02Executive Chairman recently bought ₹536k worth of stockOn the 30th of March, Arun Kothari bought around 1k shares on-market at roughly ₹536 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹4.6m worth in shares.Board Change • Apr 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Mar 16Executive Chairman recently bought ₹1.6m worth of stockOn the 9th of March, Arun Kothari bought around 3k shares on-market at roughly ₹521 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹3.7m worth in shares.Board Change • Mar 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 17Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹13.96 (up from ₹10.72 in 3Q 2021). Revenue: ₹777.3m (up 19% from 3Q 2021). Net income: ₹79.7m (up 30% from 3Q 2021). Profit margin: 10% (in line with 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.분석 기사 • Feb 14Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹673, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 72% over the past three years.Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹22.20 (vs ₹17.16 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹863.4m (up 20% from 2Q 2021). Net income: ₹126.7m (up 29% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 14% per year.분석 기사 • Sep 08We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For NowShareholders of Albert David Limited ( NSE:ALBERTDAVD ) will have been dismayed by the negative share price return over...Upcoming Dividend • Aug 30Upcoming dividend of ₹6.00 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 14 October 2021. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.8%).Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹18.30 (vs ₹7.65 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹861.5m (up 37% from 1Q 2021). Net income: ₹104.5m (up 139% from 1Q 2021). Profit margin: 12% (up from 7.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹612, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 13% over the past three years.Reported Earnings • Jun 20Full year 2021 earnings released: EPS ₹38.80 (vs ₹33.59 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹2.47b (down 23% from FY 2020). Net income: ₹221.4m (up 16% from FY 2020). Profit margin: 8.9% (up from 6.0% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Recent Insider Transactions • Apr 04Insider recently bought ₹189k worth of stockOn the 30th of March, Anand Kothari bought around 500 shares on-market at roughly ₹379 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹199k. Insiders have collectively bought ₹389k more in shares than they have sold in the last 12 months.Recent Insider Transactions • Mar 31Executive Chairman recently bought ₹199k worth of stockOn the 22nd of March, Arun Kothari bought around 500 shares on-market at roughly ₹398 per share. This was the largest purchase by an insider in the last 3 months. This was Arun's only on-market trade for the last 12 months.Is New 90 Day High Low • Feb 17New 90-day low: ₹405The company is down 2.0% from its price of ₹411 on 19 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 11% over the same period.Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹10.72 (vs ₹9.20 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹701.8m (down 12% from 3Q 2020). Net income: ₹61.2m (up 17% from 3Q 2020). Profit margin: 8.7% (up from 6.6% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.분석 기사 • Feb 06Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Albert David Limited...분석 기사 • Jan 22Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?Albert David's (NSE:ALBERTDAVD) stock up by 6.4% over the past three months. We wonder if and what role the company's...분석 기사 • Jan 07Why Albert David's (NSE:ALBERTDAVD) CEO Pay MattersTarminder Parmar has been the CEO of Albert David Limited ( NSE:ALBERTDAVD ) since 2017, and this article will examine...분석 기사 • Dec 23Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...분석 기사 • Dec 08Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too ConservativeIt might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...Is New 90 Day High Low • Nov 24New 90-day high: ₹460The company is up 2.0% from its price of ₹453 on 26 August 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 1.0% over the same period.매출 및 비용 세부 내역Albert David가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NSEI:ALBERTDAVD 매출, 비용 및 순이익 (INR Millions)날짜매출순이익일반관리비연구개발비31 Mar 263,336-151,025031 Dec 253,226961,192030 Sep 253,158-1511,239030 Jun 253,270631,262031 Mar 253,4581721,261031 Dec 243,5994041,213030 Sep 243,6516851,158030 Jun 243,5997081,068031 Mar 243,6257541,007031 Dec 233,548662909030 Sep 233,411581881030 Jun 233,403579886031 Mar 233,416362890031 Dec 223,345366926030 Sep 223,316340927030 Jun 223,256266936031 Mar 223,135353935031 Dec 212,959384911030 Sep 212,895365906030 Jun 212,748337828031 Mar 212,474221887031 Dec 202,507116942030 Sep 202,650107954030 Jun 202,82988976031 Mar 203,208192994031 Dec 193,2852991,004030 Sep 193,2592721,015030 Jun 193,1411981,024031 Mar 193,1691771,013031 Dec 183,1601791,026030 Sep 183,1362061,001030 Jun 183,271287993031 Mar 182,874135971031 Dec 172,976761,055030 Sep 172,799171,065030 Jun 172,78441,059031 Mar 172,9491711,003031 Dec 163,0081031,040030 Sep 163,130681,029030 Jun 163,16570840031 Mar 163,22672987031 Dec 153,229811,4563930 Sep 153,2551391,4413930 Jun 153,2431461,42539양질의 수익: ALBERTDAVD 은(는) 현재 수익성이 없습니다.이익 마진 증가: ALBERTDAVD는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: ALBERTDAVD은 수익성이 없으며 지난 5년 동안 손실이 연평균 11.1% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 ALBERTDAVD의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: ALBERTDAVD은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(15.8%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: ALBERTDAVD는 현재 수익성이 없으므로 자본 수익률이 음수(-0.38%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/22 05:30종가2026/06/22 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Albert David Limited는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kameswari V. S. ChavaliFirstCall Research
Reported Earnings • May 14Full year 2026 earnings released: ₹2.62 loss per share (vs ₹30.14 profit in FY 2025)Full year 2026 results: ₹2.62 loss per share (down from ₹30.14 profit in FY 2025). Revenue: ₹3.41b (down 1.4% from FY 2025). Net loss: ₹14.9m (down 109% from profit in FY 2025). Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
공시 • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
공시 • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026
Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
공시 • Nov 03Albert David Limited to Report Q2, 2026 Results on Nov 12, 2025Albert David Limited announced that they will report Q2, 2026 results on Nov 12, 2025
Declared Dividend • May 14Dividend of ₹5.00 announcedDividend of ₹5.00 is the same as last year. Ex-date: 30th July 2026 Payment date: 5th September 2026 Dividend yield will be 0.7%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.
Reported Earnings • May 14Full year 2026 earnings released: ₹2.62 loss per share (vs ₹30.14 profit in FY 2025)Full year 2026 results: ₹2.62 loss per share (down from ₹30.14 profit in FY 2025). Revenue: ₹3.41b (down 1.4% from FY 2025). Net loss: ₹14.9m (down 109% from profit in FY 2025). Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
공시 • May 13Albert David Limited, Annual General Meeting, Aug 06, 2026Albert David Limited, Annual General Meeting, Aug 06, 2026.
공시 • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
분석 기사 • Feb 14Is Albert David (NSE:ALBERTDAVD) Weighed On By Its Debt Load?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
공시 • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026
Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
공시 • Nov 03Albert David Limited to Report Q2, 2026 Results on Nov 12, 2025Albert David Limited announced that they will report Q2, 2026 results on Nov 12, 2025
공시 • Jul 25Albert David Limited to Report Q1, 2026 Results on Aug 02, 2025Albert David Limited announced that they will report Q1, 2026 results at 12:15 PM, Indian Standard Time on Aug 02, 2025
Upcoming Dividend • Jul 18Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 25 July 2025. Payment date: 07 August 2025. Payout ratio is a comfortable 17% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.8%).
Reported Earnings • Jul 10Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.46b (down 4.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 5.0% (down from 21% in FY 2024). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 16% per year.
분석 기사 • May 24Albert David's (NSE:ALBERTDAVD) Weak Earnings May Only Reveal A Part Of The Whole PictureThe market wasn't impressed with the soft earnings from Albert David Limited ( NSE:ALBERTDAVD ) recently. Our analysis...
Declared Dividend • May 15Dividend reduced to ₹5.00Dividend of ₹5.00 is 57% lower than last year. Ex-date: 25th July 2025 Payment date: 1st September 2025 Dividend yield will be 0.6%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to decline by 90% to shift the payout ratio to a potentially unsustainable range, which is more than the 2.1% EPS decline seen over the last 5 years.
공시 • May 14+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 02, 2025Albert David Limited, Annual General Meeting, Aug 02, 2025.
Reported Earnings • May 14Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.75b (up 3.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 4.6% (down from 21% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 15% per year.
New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (9.0% average weekly change). Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (₹5.14b market cap, or US$60.5m).
공시 • Mar 10Albert David Limited Announces Resignation of Shirish Gundopant Belapure as Independent DirectorAlbert David Limited announced that Mr. Shirish Gundopant Belapure has tendered his resignation as an Independent Director of the company, with effect from March 10, 2025.
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹885, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 28x in the Pharmaceuticals industry in India. Total returns to shareholders of 69% over the past three years.
분석 기사 • Feb 14Albert David Limited (NSE:ALBERTDAVD) Not Doing Enough For Some Investors As Its Shares Slump 27%The Albert David Limited ( NSE:ALBERTDAVD ) share price has fared very poorly over the last month, falling by a...
Reported Earnings • Feb 13Third quarter 2025 earnings released: ₹16.45 loss per share (vs ₹32.80 profit in 3Q 2024)Third quarter 2025 results: ₹16.45 loss per share (down from ₹32.80 profit in 3Q 2024). Revenue: ₹740.8m (down 16% from 3Q 2024). Net loss: ₹93.9m (down 150% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
공시 • Feb 01Albert David Limited to Report Q3, 2025 Results on Feb 12, 2025Albert David Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 12, 2025
분석 기사 • Nov 22Albert David's (NSE:ALBERTDAVD) Attractive Earnings Are Not All Good News For ShareholdersThe latest earnings release from Albert David Limited ( NSE:ALBERTDAVD ) disappointed investors. We did some digging...
Reported Earnings • Nov 17Second quarter 2025 earnings released: EPS: ₹31.67 (vs ₹35.57 in 2Q 2024)Second quarter 2025 results: EPS: ₹31.67 (down from ₹35.57 in 2Q 2024). Revenue: ₹1.19b (up 28% from 2Q 2024). Net income: ₹180.7m (down 11% from 2Q 2024). Profit margin: 15% (down from 22% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 30% per year.
공시 • Nov 09Albert David Limited to Report Q2, 2025 Results on Nov 14, 2024Albert David Limited announced that they will report Q2, 2025 results on Nov 14, 2024
분석 기사 • Aug 31A Piece Of The Puzzle Missing From Albert David Limited's (NSE:ALBERTDAVD) 26% Share Price ClimbDespite an already strong run, Albert David Limited ( NSE:ALBERTDAVD ) shares have been powering on, with a gain of 26...
Buy Or Sell Opportunity • Aug 29Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 46% to ₹1,629. The fair value is estimated to be ₹1,314, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Earnings per share has grown by 31%.
Valuation Update With 7 Day Price Move • Aug 23Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹1,448, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 37x in the Pharmaceuticals industry in India. Total returns to shareholders of 163% over the past three years.
공시 • Aug 09Albert David Limited Approves Dividend for the Financial Year Ended on March 31, 2024Albert David Limited at the Annual General Meeting held on August 9, 2024 approved declaration of Dividend of INR 11.50 per equity share of INR 10 each for the financial year ended on March 31, 2024.
분석 기사 • Jul 30Albert David (NSE:ALBERTDAVD) Is Increasing Its Dividend To ₹11.50Albert David Limited ( NSE:ALBERTDAVD ) has announced that it will be increasing its dividend from last year's...
Buy Or Sell Opportunity • Jul 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 11% to ₹1,326. The fair value is estimated to be ₹1,103, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.
Upcoming Dividend • Jul 26Upcoming dividend of ₹11.50 per shareEligible shareholders must have bought the stock before 02 August 2024. Payment date: 08 September 2024. Payout ratio is a comfortable 8.7% and this is well supported by cash flows. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).
분석 기사 • Jul 16Albert David (NSE:ALBERTDAVD) Has Announced That It Will Be Increasing Its Dividend To ₹11.50Albert David Limited ( NSE:ALBERTDAVD ) has announced that it will be increasing its dividend from last year's...
Reported Earnings • Jul 15Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹3.62b (up 6.1% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 21% (up from 11% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.
Buy Or Sell Opportunity • Jul 01Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to ₹1,361. The fair value is estimated to be ₹1,103, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.
Buy Or Sell Opportunity • Jun 21Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to ₹1,335. The fair value is estimated to be ₹1,105, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.
Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,269, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 33x in the Pharmaceuticals industry in India. Total returns to shareholders of 156% over the past three years.
분석 기사 • May 21We Think That There Are Issues Underlying Albert David's (NSE:ALBERTDAVD) EarningsUnsurprisingly, Albert David Limited's ( NSE:ALBERTDAVD ) stock price was strong on the back of its healthy earnings...
Declared Dividend • May 15Dividend of ₹11.50 announcedShareholders will receive a dividend of ₹11.50. Ex-date: 2nd August 2024 Payment date: 8th September 2024 Dividend yield will be 1.0%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (14% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 34% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • May 15Albert David Limited, Annual General Meeting, Aug 09, 2024Albert David Limited, Annual General Meeting, Aug 09, 2024.
Reported Earnings • May 14Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹4.20b (up 23% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 18% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.
공시 • May 07Albert David Limited to Report Q4, 2024 Results on May 13, 2024Albert David Limited announced that they will report Q4, 2024 results on May 13, 2024
공시 • May 06Albert David Limited Announces Resignation of Abhishek Seth as Company Secretary & Compliance Officer, Effective May 31, 2024Albert David Limited informed that Mr. Abhishek Seth (ACS - 39671), Company Secretary & Compliance Officer, has resigned from the services of the Company effective May 31, 2024, in view of career opportunity outside the organization. In view of the resignation, Mr. Seth will also cease to be a Key Managerial Person under the provisions of Section 203 and other applicable provisions, if any, of the Companies Act, 2013 and Regulation 30(5) of the SEBI Listing Regulations for determining materiality of events /information for disclosure to the Stock Exchanges.
분석 기사 • Mar 20Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price SlumpAlbert David Limited ( NSE:ALBERTDAVD ) shares have retraced a considerable 25% in the last month, reversing a fair...
공시 • Mar 14Albert David Limited Announces Management ChangesAlbert David Limited at its board meeting held on 14 March 2024 announced that Based on the recommendation of the Nomination and Remuneration Committee of the Company, appointed Mr. Abhishek Seth (ACS-39671) as the Company Secretary & Compliance Officer, Nodal Officer (IEPF) and Chief Investor Relations Officer of the Company effective 14th March 2024 and Noted that Mr. Rajiv Singhi (DIN:00071285) and Mr. Hemal Kampani (DIN:00057715), Independent Directors of the Company, will be completing their second & final term as Independent Directors effective end of day 31st March 2024, and, thus, placed on record their appreciation for the retiring Directors. Reason for change of Mr. Abhishek Seth: In view of resignation of earlier Company Secretary & Compliance Officer-cum-Legal Head of the Company, and, based on recommendation of the Nomination and Remuneration Committee of the Company, the Board has appointed Mr. Abhishek Seth as the Company Secretary & Compliance Officer of the Company, who shall also function as the Nodal Officer (IEPF) and Chief Investor Relations Officer. Mr. Abhishek Seth is an Associate Member of the Institute of Company Secretaries of India (Membership No. 39671) and holds a Master's in Economics from University of Calcutta. He has around 9 years of post-qualification experience in the Corporate Secretarial and Compliance domain. He has been associated with Albert David Limited for nearly 8 years across Corporate Secretarial, Compliance and Finance functions. Prior to association with Albert David Limited, he was associated with Bengal Shelter Housing Development Limited as Company Secretary.
Reported Earnings • Feb 06Third quarter 2024 earnings released: EPS: ₹32.80 (vs ₹18.48 in 3Q 2023)Third quarter 2024 results: EPS: ₹32.80 (up from ₹18.48 in 3Q 2023). Revenue: ₹1.05b (up 41% from 3Q 2023). Net income: ₹187.2m (up 78% from 3Q 2023). Profit margin: 18% (up from 14% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Jan 26Albert David Limited to Report Q3, 2024 Results on Feb 05, 2024Albert David Limited announced that they will report Q3, 2024 results on Feb 05, 2024
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,271, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 35x in the Pharmaceuticals industry in India. Total returns to shareholders of 207% over the past three years.
분석 기사 • Jan 20The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do MoreAlbert David Limited ( NSE:ALBERTDAVD ) shares have continued their recent momentum with a 33% gain in the last month...
공시 • Nov 23Albert David Limited Announces Resignation of A. B. Chakrabartty as Company Secretary and Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that Mr. A. B. Chakrabartty (FCS 7184) has conveyed his decision to resign from the post of Company Secretary and Compliance Officer cum Legal Head of the Company, due to career opportunity outside the organization. He will continue to discharge his duties as the Company Secretary and Compliance Officer cum Legal Head of the Company, until the close of business hours on 19 January, 2024 to facilitate smooth transition. The Company has accepted his resignation. Mr. Chakrabartty will also cease to be a Key Managerial Personnel under the provisions of Section 203 and other applicable provisions, if any of the Companies Act, 2023 and Regulation 30(5) of SEBI LODR for determining the materiality of events or transactions for making the required disclosures to the Stock Exchanges effective close of business hours on January 19, 2024.
Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹35.57 (vs ₹35.29 in 2Q 2023)Second quarter 2024 results: EPS: ₹35.57 (up from ₹35.29 in 2Q 2023). Revenue: ₹1.05b (up 14% from 2Q 2023). Net income: ₹203.0m (flat on 2Q 2023). Profit margin: 19% (down from 22% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
공시 • Aug 11Albert David Limited Approves Dividend for the Financial Year Ended March 31, 2023Albert David Limited at its AGM held on August 10, 2023 approved dividend of INR 9.00 per equity share of INR 10.00 each for the financial year ended on 31st March, 2023.
Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹41.16 (vs ₹3.08 in 1Q 2023)First quarter 2024 results: EPS: ₹41.16 (up from ₹3.08 in 1Q 2023). Revenue: ₹1.10b (up 18% from 1Q 2023). Net income: ₹234.9m (up ₹217.4m from 1Q 2023). Profit margin: 21% (up from 1.9% in 1Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
공시 • Aug 03Albert David Limited to Report Q1, 2024 Results on Aug 10, 2023Albert David Limited announced that they will report Q1, 2024 results on Aug 10, 2023
Upcoming Dividend • Jul 27Upcoming dividend of ₹9.00 per share at 1.3% yieldEligible shareholders must have bought the stock before 03 August 2023. Payment date: 09 September 2023. Payout ratio is a comfortable 14% and the cash payout ratio is 98%. Trailing yield: 1.3%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%).
분석 기사 • Jul 04Albert David (NSE:ALBERTDAVD) Will Pay A Dividend Of ₹9.00Albert David Limited's ( NSE:ALBERTDAVD ) investors are due to receive a payment of ₹9.00 per share on 9th of...
분석 기사 • May 22Albert David (NSE:ALBERTDAVD) Is Paying Out A Dividend Of ₹9.00The board of Albert David Limited ( NSE:ALBERTDAVD ) has announced that it will pay a dividend on the 9th of September...
Reported Earnings • May 21Full year 2023 earnings released: EPS: ₹63.39 (vs ₹61.78 in FY 2022)Full year 2023 results: EPS: ₹63.39 (up from ₹61.78 in FY 2022). Revenue: ₹3.57b (up 14% from FY 2022). Net income: ₹361.7m (up 2.6% from FY 2022). Profit margin: 10% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
공시 • May 20+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 10, 2023Albert David Limited, Annual General Meeting, Aug 10, 2023. Agenda: To consider dividend for the financial year ended March 31, 2023; and to consider directorate appointments.
공시 • May 13Albert David Limited to Report Q4, 2023 Results on May 19, 2023Albert David Limited announced that they will report Q4, 2023 results on May 19, 2023
Reported Earnings • Feb 15Third quarter 2023 earnings released: EPS: ₹18.48 (vs ₹13.96 in 3Q 2022)Third quarter 2023 results: EPS: ₹18.48 (up from ₹13.96 in 3Q 2022). Revenue: ₹745.7m (up 4.0% from 3Q 2022). Net income: ₹105.5m (up 32% from 3Q 2022). Profit margin: 14% (up from 11% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
공시 • Feb 07Albert David Limited to Report Q3, 2023 Results on Feb 13, 2023Albert David Limited announced that they will report Q3, 2023 results on Feb 13, 2023
공시 • Feb 06+ 1 more updateAlbert David Limited Appoints Mr. A B Chakrabartty as the Company Secretary & Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that at its board meeting held on February 04, 2023, the board approved the appointment of Mr. A B Chakrabartty as the Company Secretary & Compliance officer cum Legal Head of the company with effect from February 04, 2023.
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹35.29 (vs ₹22.20 in 2Q 2022)Second quarter 2023 results: EPS: ₹35.29 (up from ₹22.20 in 2Q 2022). Revenue: ₹1.06b (up 23% from 2Q 2022). Net income: ₹201.4m (up 59% from 2Q 2022). Profit margin: 19% (up from 15% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Jul 25Upcoming dividend of ₹9.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 08 September 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (1.0%).
Reported Earnings • Jul 17Full year 2022 earnings releasedFull year 2022 results: Revenue: ₹3.14b (up 27% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021).
Recent Insider Transactions • Jun 19Executive Chairman recently bought ₹1.1m worth of stockOn the 13th of June, Arun Kothari bought around 2k shares on-market at roughly ₹526 per share. In the last 3 months, they made an even bigger purchase worth ₹1.4m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹7.3m worth in shares.
Reported Earnings • May 13Full year 2022 earnings released: EPS: ₹61.78 (vs ₹38.80 in FY 2021)Full year 2022 results: EPS: ₹61.78 (up from ₹38.80 in FY 2021). Revenue: ₹3.29b (up 33% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Apr 02Executive Chairman recently bought ₹536k worth of stockOn the 30th of March, Arun Kothari bought around 1k shares on-market at roughly ₹536 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹4.6m worth in shares.
Board Change • Apr 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Mar 16Executive Chairman recently bought ₹1.6m worth of stockOn the 9th of March, Arun Kothari bought around 3k shares on-market at roughly ₹521 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹3.7m worth in shares.
Board Change • Mar 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 17Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹13.96 (up from ₹10.72 in 3Q 2021). Revenue: ₹777.3m (up 19% from 3Q 2021). Net income: ₹79.7m (up 30% from 3Q 2021). Profit margin: 10% (in line with 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
분석 기사 • Feb 14Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹673, the stock trades at a trailing P/E ratio of 9.4x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 72% over the past three years.
Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹22.20 (vs ₹17.16 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹863.4m (up 20% from 2Q 2021). Net income: ₹126.7m (up 29% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 14% per year.
분석 기사 • Sep 08We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For NowShareholders of Albert David Limited ( NSE:ALBERTDAVD ) will have been dismayed by the negative share price return over...
Upcoming Dividend • Aug 30Upcoming dividend of ₹6.00 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 14 October 2021. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.8%).
Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹18.30 (vs ₹7.65 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹861.5m (up 37% from 1Q 2021). Net income: ₹104.5m (up 139% from 1Q 2021). Profit margin: 12% (up from 7.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.
Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹612, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 13% over the past three years.
Reported Earnings • Jun 20Full year 2021 earnings released: EPS ₹38.80 (vs ₹33.59 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹2.47b (down 23% from FY 2020). Net income: ₹221.4m (up 16% from FY 2020). Profit margin: 8.9% (up from 6.0% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Apr 04Insider recently bought ₹189k worth of stockOn the 30th of March, Anand Kothari bought around 500 shares on-market at roughly ₹379 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹199k. Insiders have collectively bought ₹389k more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Mar 31Executive Chairman recently bought ₹199k worth of stockOn the 22nd of March, Arun Kothari bought around 500 shares on-market at roughly ₹398 per share. This was the largest purchase by an insider in the last 3 months. This was Arun's only on-market trade for the last 12 months.
Is New 90 Day High Low • Feb 17New 90-day low: ₹405The company is down 2.0% from its price of ₹411 on 19 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 11% over the same period.
Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹10.72 (vs ₹9.20 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹701.8m (down 12% from 3Q 2020). Net income: ₹61.2m (up 17% from 3Q 2020). Profit margin: 8.7% (up from 6.6% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.
분석 기사 • Feb 06Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Albert David Limited...
분석 기사 • Jan 22Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?Albert David's (NSE:ALBERTDAVD) stock up by 6.4% over the past three months. We wonder if and what role the company's...
분석 기사 • Jan 07Why Albert David's (NSE:ALBERTDAVD) CEO Pay MattersTarminder Parmar has been the CEO of Albert David Limited ( NSE:ALBERTDAVD ) since 2017, and this article will examine...
분석 기사 • Dec 23Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
분석 기사 • Dec 08Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too ConservativeIt might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...
Is New 90 Day High Low • Nov 24New 90-day high: ₹460The company is up 2.0% from its price of ₹453 on 26 August 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Pharmaceuticals industry, which is up 1.0% over the same period.